About Us

Our People

DAVA Oncology

DAVA Oncology is led by a team of highly experienced senior managers, who have played an integral role in the company’s success. Their commitment to quality and innovation is unparalleled. Our team is capable and eager to lead the organization through sustained and rapid growth in our endeavors.  DAVA Oncology’s senior management team brings a wealth of broad medical, scientific and business experience, with an average of over 20 years in the both the biopharmaceutical industry and clinical medicine.

Executive Management

Mark Levonyak
President

  • Broad pharmaceutical industry experience, including new product planning and commercialization

  • Launched three oncology products (Kytril, Hycamtin, Trisenox)

  • Instrumental in new product planning for four oncology products (Xyotax, Xyocam, Pixantrone, Mozobil)

  • Developed and led 3 oncology sales and marketing teams (SmithKline Beecham, Cell Therapeutics, AnorMED)

John Eckardt, MD
Chief Medical Officer

  • Board certified Medical Oncologist

  • Trained in Oncology Drug Development under Dr. Dan Von Hoff in San Antonio, Texas

  • Private practice medical oncologist since 1993

  • Developed community-based clinical research program for Phase I, II, and III clinical trials

Active clinical speaker for lung cancer, breast cancer and new drug development

Gregory Pynes, MPA
Executive Director, Meetings, Branding, and Partnerships

  • Extensive professional oncology experience in CME and On Label Meeting Management

  • Senior Director of Meetings and Partnerships, Physicians’ Education Resource, 2001-2011

  • Brand Management

  • Academic and Practice Partnership development